Clustering data with hclust algorithm for Metabolites changes related to glucose-mediated energy production in chemotheraphy-induced cachexia (Study ST001467)

Reversed phase NEGATIVE ION MODE (Analysis AN002442)
MetaboliteStructureF1F2F3F4F5F6F7F8F9F10F11F12
Fructose 1,6-bisphosphateME3434720.120.061.480.105.820.120.410.051.200.071.510.11
Glucose 6-phosphateME3434710.140.111.330.166.280.230.410.110.980.171.110.22
3-Phosphoglyceric acidME3434730.260.421.430.423.720.720.510.390.960.431.380.57
Adenosine triphosphateME3434820.550.132.230.163.170.260.980.091.380.081.760.31
Citric acidME3434770.010.460.011.610.022.930.010.500.011.390.023.44
L-Lactic acidME3434760.301.620.531.500.571.630.471.130.501.460.531.54
Pyruvic acidME3434750.261.530.521.550.501.720.471.050.551.360.581.58
6-Phosphogluconic acidME3434830.040.880.082.280.122.560.031.130.051.700.062.18
Ribose 1,5-bisphosphateME3434850.181.570.181.850.182.060.091.250.091.950.092.07
D-GlucoseME3434700.160.940.351.700.391.860.231.240.341.840.311.92
D-Sedoheptulose 7-phosphateME3434860.170.850.311.570.522.190.180.950.221.500.222.42
Adenosine monophosphateME3434811.430.880.880.401.420.741.750.541.350.521.890.47
D-Ribose 5-phosphateME3434841.790.461.560.521.580.811.220.411.310.511.130.73
Phosphoenolpyruvic acidME3434740.180.641.520.712.381.160.310.620.940.680.961.02
Succinic acidME3434780.330.290.840.781.691.380.510.330.700.991.151.76
Fumaric acidME3434790.690.260.980.711.421.530.640.250.640.600.802.36
Malic acidME3434800.560.470.860.571.271.900.460.550.480.780.622.51

Factors:

F1Group:batch1 | Treatment:5FU | Sample Source:muscle
F2Group:batch1 | Treatment:5FU | Sample Source:plasma
F3Group:batch1 | Treatment:BST204 | Sample Source:muscle
F4Group:batch1 | Treatment:BST204 | Sample Source:plasma
F5Group:batch1 | Treatment:Control | Sample Source:muscle
F6Group:batch1 | Treatment:Control | Sample Source:plasma
F7Group:batch2 | Treatment:5FU | Sample Source:muscle
F8Group:batch2 | Treatment:5FU | Sample Source:plasma
F9Group:batch2 | Treatment:BST204 | Sample Source:muscle
F10Group:batch2 | Treatment:BST204 | Sample Source:plasma
F11Group:batch2 | Treatment:Control | Sample Source:muscle
F12Group:batch2 | Treatment:Control | Sample Source:plasma
Data matrix
  logo